XLARET Trademark

Trademark Overview

On Thursday, November 17, 2005, a trademark application was filed for XLARET with the United States Patent and Trademark Office. The USPTO has given the XLARET trademark a serial number of 79020851. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, November 6, 2014. This trademark is owned by NOVARTIS AG. The XLARET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals
xlaret

General Information

Serial Number79020851
Word MarkXLARET
Filing DateThursday, November 17, 2005
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, November 6, 2014
Registration Number3228113
Registration DateTuesday, April 10, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system including diabetes, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 15, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, January 26, 2015INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, November 21, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 21, 2014DEATH OF INTERNATIONAL REGISTRATION
Tuesday, July 15, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 15, 2013CANCELLED SECTION 71
Friday, April 12, 2013NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 23, 2013CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, June 20, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2009LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Thursday, April 2, 2009LIMITATION OF GOODS RECEIVED FROM IB
Friday, June 27, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 1, 2007FINAL DISPOSITION NOTICE SENT TO IB
Monday, October 1, 2007FINAL DISPOSITION PROCESSED
Tuesday, September 25, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 10, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, January 23, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2007NOTICE OF PUBLICATION
Thursday, November 30, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 29, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 29, 2006EXAMINER'S AMENDMENT ENTERED
Wednesday, November 29, 2006EXAMINERS AMENDMENT E-MAILED
Wednesday, November 29, 2006EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 28, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, November 28, 2006ASSIGNED TO LIE
Tuesday, November 28, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, November 28, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, November 9, 2006ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 9, 2006TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 15, 2006REFUSAL PROCESSED BY IB
Wednesday, May 31, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 31, 2006REFUSAL PROCESSED BY MPU
Monday, May 29, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, May 28, 2006NON-FINAL ACTION WRITTEN
Thursday, May 25, 2006NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Wednesday, May 24, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, May 23, 2006NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2006ASSIGNED TO EXAMINER
Friday, March 24, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, March 23, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

xlaret system treatment disorders preparations prevention pharmaceutical diseases anti ocular gastroenterological